A comparison between revised Manchester Point A and ICRU-89-recommended Point A definition absorbed-dose reporting using CT images in intracavitary brachytherapy for patients with cervical carcinoma.
American Brachytherapy Society
Cervix carcinoma
High-dose-rate brachytherapy
ICRU
Intracavitary brachytherapy
Point A
Journal
Brachytherapy
ISSN: 1873-1449
Titre abrégé: Brachytherapy
Pays: United States
ID NLM: 101137600
Informations de publication
Date de publication:
Historique:
received:
27
05
2020
revised:
01
07
2020
accepted:
13
07
2020
pubmed:
20
8
2020
medline:
20
8
2021
entrez:
20
8
2020
Statut:
ppublish
Résumé
This study is a comparison between revised Manchester Point A and International Commission on Radiation Units and measurements (ICRU) 89 report-recommended Point A absorbed-dose reporting in intracavitary brachytherapy for patients with cervical carcinoma. The retrospective dosimetric study is based on the data of 32 patients with cervical carcinoma treated with high-dose-rate brachytherapy. Patients received 21 Gy in three fractions (7.0 Gy X three fractions) to Point A (A When using the A It has been found that the position of revised Manchester (A
Identifiants
pubmed: 32811759
pii: S1538-4721(20)30146-X
doi: 10.1016/j.brachy.2020.07.009
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
118-127Informations de copyright
Copyright © 2021 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.